Semaglutide works on GLP1 pathways in the brain and gut to reduce appetite, slow stomach emptying, and improve metabolic markers
Increased Muscle Mass: Facilitates muscle growth and development
An experimental drug from Lilly, eloralintide, led to an average 11.3% weight loss over 12 weeks in a Phase 1 study, according to new results published last week at the diabetes conference
Cinnamon use in type 2 diabetes: an updated systematic review and meta-analysis. Annals of Family Medicine, 2013
Gordon Smith A, Robinson Singleton J
Os inibidores SGLT2 mostraram benefcio em pacientes com insuficincia cardaca ou doena renal crnica, e os anlogos GLP-1 so utilizados no tratamento da obesidade e em pacientes com alto risco ou doena cardiovascular estabelecida